Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-06

Clinical Trial Update: Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management [Phase 1]

View source ↗

Summary

Phase 1 trial comparing azithromycin and erythromycin for the management of preterm premature rupture of membranes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: District Headquarters Teaching Hospital Sahiwal | Conditions: Pre-term Premature Rupture of Membranes | Phase 1 | Status: COMPLETED